Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Font Size

FDA Approves Prostate Cancer Drug

Zytiga Fights Treatment-Resistant Prostate Cancer

Side Effects

Commonly reported side effects of Zytiga included joint swelling or discomfort, low levels of potassium in the blood, fluid retention, usually in the legs and feet, muscle discomfort, hot flashes, diarrhea, and urinary tract infection.

Other side effects included cough, high blood pressure, heartbeat disorders, urinary frequency, increased nighttime urination, upset stomach or indigestion, and upper respiratory tract infection.

Centocor, based in Horsham, Pa., says in a statement that the FDA’s approval of Zytiga represents a step forward in the treatment of metastatic prostate cancer.

“As a clinician, I believe the efficacy and safety profile of abiraterone acetate, as well as its oral, once-daily formulation, will help address the important need for additional therapeutic choices for men living with this serious disease,” Howard Scher, MD, of Memorial Sloan-Kettering Cancer Center in New York, says in the company’s news release.

Johann S. de Bono, MD, PhD, MSc, FRCP, of the Royal Marsden NHS Foundation Trust in London, says in the company’s statement that the approval of the drug marks “an exciting time for men with prostate cancer.”

The drug’s approval also was praised in the company’s statement by Wendy L. Poage, MHA, president of the Colorado-based Prostate Conditions Education Council.

Prostate cancer forms in tissues of the prostate, a gland in the male reproductive system below the bladder, and usually occurs in older men, according to the National Cancer Institute (NCI). The NCI says 217,730 new cases of the disease were reported in 2010 and 32,050 men died of prostate cancer.

1 | 2

Today on WebMD

man with doctor
Symptoms, risks, treatments
man coughing
Men shouldn’t ignore
prostate cancer cells
What does this diagnosis mean?
doctor and male patient
Is it worth it?
cancer fighting foods
15 Cancer Symptoms Men Ignore
Prostate Enlarged
Picture Of The Prostate
Prostate Cancer Quiz
screening tests for men
Prostate Cancer Symptoms
Vitamin D